Neil E. Stahl - EVP Research and Development at REGENERON PHARMACEUTICALS, INC.

Issuer-level insider activity

Role
EVP Research and Development
Issuer ticker
REGN on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Neil E. Stahl since 27 Aug 2025

Reported holdings for Neil E. Stahl in REGENERON PHARMACEUTICALS, INC.

Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
48,829
Estimated value
$35,684,721
Report date
16 Dec 2024
Price
$730.81
Ownership
Direct
Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
5,849
Estimated value
$4,274,508
Report date
16 Dec 2024
Price
$730.81
Ownership
By 401(k) Plan
Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Common Stock
Shares / value
4,605
Estimated value
$3,365,380
Report date
16 Dec 2024
Price
$730.81
Ownership
by Spouse as Trustee
Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
45,000
Estimated value
Report date
02 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP Research and Development

REGENERON PHARMACEUTICALS, INC.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
02 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Neil E. Stahl in REGENERON PHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .